Digital PCR Market / Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share & Trends by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029
The global digital PCR (dPCR) and real-time PCR (qPCR) market is projected to reach USD 14.8 billion by 2029 from USD 10.0 billion in 2024, at a CAGR of 8.1% during the forecast period of 2024 to 2029. The growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market has been significantly driven by its increasing adoption among hospital and diagnostics laboratories for disease diagnosis application, increasing R&D investment by key players for the development and launch of innovative product and continuous advancements in PCR technologies. However, high instrument costs especially that of dPCR and the technical limitations of PCR are restraining market growth.
“The infectious disease testing segment under clinical application segment accounted for the largest share by application in 2023.”
In 2023, the infectious disease testing segment under clinical application segment accounted for the largest share by application in the global digital PCR (dPCR) and real-time PCR (qPCR) market. qPCR has revolutionized infectious disease diagnostics by providing rapid, sensitive, and specific detection of pathogens. It is useful in identifying bacteria, viruses, fungi, and parasites, enabling early diagnosis and effective treatment. During the past decade, clinical laboratories worldwide have been increasing using qPCR for pathogen testing and the diagnosis of infectious and sexually transmitted diseases. Advanced molecular diagnosis tools such as spectroscopy and liquid chromatography are being integrated with qPCR workflows to offer genomic lab technicians the capability of rapid and accurate pathogen detection.
“The US has continued to dominate the digital PCR (dPCR) and real-time PCR (qPCR) market during the forecast period of 2024-2029.”
The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for digital PCR (dPCR) and real-time PCR (qPCR) products is expected to grow in the coming years, driven by the rising patient population suffering from infectious disease, increasing focus on biopharmaceuticals, and the need for safe & high-quality products in the healthcare industry. The nation has a highly advanced market in terms of R&D due to the presence of better infrastructure, government support, and private funding. This helps develop innovative and advanced technologies for research. Pharmaceutical companies in the US are actively participating in the development of novel reagent and test assays and utilizing it with Digital PCR (dPCR) and real-time PCR (qPCR), which offers less turnaround time, and is energy-efficient also provide accurate results, with in a span of time. These factors are supporting the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market in the country.
The primary interviews conducted for this report can be categorized as follows:
Danaher Corporation (US)
F. Hoffmann-La Roche Ltd (Switzerland)
Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
Qiagen N.V. (Germany)
Abbott Laboratories (US)
Biomerieux (France)
Becton, Dickinson and Company (US)
Agilent Technologies, Inc. (US)
Eppendorf AG (Germany)
Bio-Rad Laboratories, Inc. (US)
Takara Bio Inc. (Japan)
Promega Corporation (US)
Meridian Bioscience, Inc. (US)
ENDRESS+HAUSER (Switzerland)
QuidelOrtho Corporation (US)
Lepu Medical Technology Beijing Co Ltd. (China)
Sysmax Corporation (Japan)
Enzo Biochem, Inc. (US)
Biocartis (Belgium)
Stilla Technologies (France)
Antylia Scientific (US)
Bioneer Corporation (South Korea)
Standard BioTools (US)
Seegene Inc. (South Korea)
GenScript (US)
LGC Bioresearch Technologies (England)
Quantabio (US)
Randox Laboratories Ltd. (UK)
New England Biolabs. (US)
PCR Biosystems (UK)
Research Coverage:
This research report categorizes the digital PCR (dPCR) and real-time PCR (qPCR) market by offering ((QPCR product (QPCR Reagents and Consumables, QPCR Instruments), QPCR Software, and QPCR Services) DPCR Product (QPCR Reagents and Consumables, QPCR Instruments (Droplet Digital PCR, Chip Based Digital PCR, and Beaming Digital PCR), DPCR Software, and DPCR Services)), by applications ((QPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application), and (DPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application)), by end user ((QPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others), and (DPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others)) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the Digital PCR (dPCR) and real-time PCR (qPCR) market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall digital PCR (dPCR) and real-time PCR (qPCR) market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“The infectious disease testing segment under clinical application segment accounted for the largest share by application in 2023.”
In 2023, the infectious disease testing segment under clinical application segment accounted for the largest share by application in the global digital PCR (dPCR) and real-time PCR (qPCR) market. qPCR has revolutionized infectious disease diagnostics by providing rapid, sensitive, and specific detection of pathogens. It is useful in identifying bacteria, viruses, fungi, and parasites, enabling early diagnosis and effective treatment. During the past decade, clinical laboratories worldwide have been increasing using qPCR for pathogen testing and the diagnosis of infectious and sexually transmitted diseases. Advanced molecular diagnosis tools such as spectroscopy and liquid chromatography are being integrated with qPCR workflows to offer genomic lab technicians the capability of rapid and accurate pathogen detection.
“The US has continued to dominate the digital PCR (dPCR) and real-time PCR (qPCR) market during the forecast period of 2024-2029.”
The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for digital PCR (dPCR) and real-time PCR (qPCR) products is expected to grow in the coming years, driven by the rising patient population suffering from infectious disease, increasing focus on biopharmaceuticals, and the need for safe & high-quality products in the healthcare industry. The nation has a highly advanced market in terms of R&D due to the presence of better infrastructure, government support, and private funding. This helps develop innovative and advanced technologies for research. Pharmaceutical companies in the US are actively participating in the development of novel reagent and test assays and utilizing it with Digital PCR (dPCR) and real-time PCR (qPCR), which offers less turnaround time, and is energy-efficient also provide accurate results, with in a span of time. These factors are supporting the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market in the country.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
Danaher Corporation (US)
F. Hoffmann-La Roche Ltd (Switzerland)
Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
Qiagen N.V. (Germany)
Abbott Laboratories (US)
Biomerieux (France)
Becton, Dickinson and Company (US)
Agilent Technologies, Inc. (US)
Eppendorf AG (Germany)
Bio-Rad Laboratories, Inc. (US)
Takara Bio Inc. (Japan)
Promega Corporation (US)
Meridian Bioscience, Inc. (US)
ENDRESS+HAUSER (Switzerland)
QuidelOrtho Corporation (US)
Lepu Medical Technology Beijing Co Ltd. (China)
Sysmax Corporation (Japan)
Enzo Biochem, Inc. (US)
Biocartis (Belgium)
Stilla Technologies (France)
Antylia Scientific (US)
Bioneer Corporation (South Korea)
Standard BioTools (US)
Seegene Inc. (South Korea)
GenScript (US)
LGC Bioresearch Technologies (England)
Quantabio (US)
Randox Laboratories Ltd. (UK)
New England Biolabs. (US)
PCR Biosystems (UK)
Research Coverage:
This research report categorizes the digital PCR (dPCR) and real-time PCR (qPCR) market by offering ((QPCR product (QPCR Reagents and Consumables, QPCR Instruments), QPCR Software, and QPCR Services) DPCR Product (QPCR Reagents and Consumables, QPCR Instruments (Droplet Digital PCR, Chip Based Digital PCR, and Beaming Digital PCR), DPCR Software, and DPCR Services)), by applications ((QPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application), and (DPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application)), by end user ((QPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others), and (DPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others)) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the Digital PCR (dPCR) and real-time PCR (qPCR) market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall digital PCR (dPCR) and real-time PCR (qPCR) market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Rising incidence and prevalence of target infectious diseases and genetic disorders, Continuous advancements in PCR technologies, The role of PCR in biomarker discovery, Increased use of dPCR and qPCR technologies for point of care (POC) diagnostics), restraints (High device costs associated with dPCR, Technical limitations of qPCR and dPCR, Unfavorable reimbursement scenario for diagnostic companies), opportunities (Growing market penetration in emerging countries, Integration of qPCR and dPCR with Next-Generation Sequencing (NGS), Growing significance of RT-PCR based companion diagnostics in drug development process), and Challenges (Time Consuming methodology involving in sample handling and post-PCR analysis, Lack of accuracy & standardization in protocol, Availability of alternative technologies for disease diagnosis) influencing the growth of the market).
- Product Development/Innovation: Detailed insights on newly launched products of the digital PCR (dPCR) and real-time PCR (qPCR) market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the digital PCR (dPCR) and real-time PCR (qPCR) market
- Competitive Assessment: Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Qiagen N.V. (Germany), Abbott Laboratories (US), Biomerieux (France), Becton, Dickinson and Company (US), Agilent Technologies, Inc. (US), Eppendorf AG (Germany), Bio-Rad Laboratories, Inc. (US), Takara Bio Inc. (Japan), among others in the market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKETS COVERED
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONS COVERED
FIGURE 1 REGIONAL SEGMENTATION
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
FIGURE 3 DPCR AND QPCR MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 DIGITAL PCR (DPCR) AND QUANTITATIVE PCR (QPCR) MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
2.2.1 GLOBAL MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 6 ILLUSTRATIVE EXAMPLE OF QIAGEN N.V.: REVENUE SHARE ANALYSIS (2023)
2.2.2 INSIGHTS OF PRIMARY EXPERTS
FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.2.3 SEGMENTAL MARKET SIZE ESTIMATION
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE PROJECTIONS
FIGURE 9 DPCR AND QPCR MARKET: CAGR PROJECTIONS, 2024–2029
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT ANALYSIS
2.7 RESEARCH LIMITATIONS
2.8 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 11 QPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 12 DPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 13 QPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 DPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 QPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 DPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET
4 PREMIUM INSIGHTS
4.1 DIGITAL PCR (DPCR) AND QUANTITATIVE/REAL-TIME PCR (QPCR) MARKET OVERVIEW
FIGURE 18 RISING INCIDENCE OF INFECTIOUS DISEASES AND GENETIC DISORDERS TO DRIVE MARKET DURING FORECAST PERIOD
4.2 ASIA PACIFIC: QPCR MARKET, BY OFFERING AND COUNTRY (2024)
FIGURE 19 QPCR PRODUCTS SEGMENT IN CHINA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
4.3 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET
FIGURE 20 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 DPCR AND QPCR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 3 DPCR AND QPCR MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of infectious diseases and genetic disorders
TABLE 4 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION (2022)
5.2.1.2 Increasing advancements in PCR technologies
TABLE 5 CONVENTIONAL PCR VS. QPCR & DPCR
5.2.1.3 Increasing applications of PCR in biomarker discovery
5.2.1.4 Growing focus on dPCR and qPCR technologies for POC diagnostics
5.2.2 RESTRAINTS
5.2.2.1 High cost of dPCR instruments
5.2.2.2 Technical limitations associated with qPCR and dPCR
5.2.2.3 Unfavorable reimbursements for diagnostic companies
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of emerging markets
5.2.3.2 Integration of qPCR and dPCR with NGS
5.2.3.3 Growing significance of RT-PCR-based companion diagnostics in drug development
5.2.4 CHALLENGES
5.2.4.1 Time constraints associated with sample handling
5.2.4.2 Inadequate protocols for accuracy & standardization
5.2.4.3 Availability of alternative technologies
5.3 PORTER’S FIVE FORCES ANALYSIS
FIGURE 22 DPCR AND QPCR MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6 DPCR AND QPCR MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 DEGREE OF COMPETITION
5.3.2 BARGAINING POWER OF SUPPLIERS
5.3.3 BARGAINING POWER OF BUYERS
5.3.4 THREAT OF SUBSTITUTES
5.3.5 THREAT OF NEW ENTRANTS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 23 DPCR AND QPCR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 TECHNOLOGY ANALYSIS
5.5.1 KEY TECHNOLOGIES
TABLE 7 KEY TECHNOLOGIES
5.5.2 COMPLEMENTARY TECHNOLOGIES
TABLE 8 COMPLEMENTARY TECHNOLOGIES
5.5.3 ADJACENT TECHNOLOGIES
TABLE 9 ADJACENT TECHNOLOGIES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 24 SUPPLY CHAIN ANALYSIS
5.7 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING RAW MATERIAL PROCUREMENT AND MANUFACTURING STAGES
5.8 PRICING ANALYSIS
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT (2023)
FIGURE 26 AVERAGE SELLING PRICE TREND FOR QPCR INSTRUMENTS (2021?2023)
TABLE 11 AVERAGE SELLING PRICE, BY PRODUCT, BY REGION (2023)
5.9 ECOSYSTEM ANALYSIS
FIGURE 27 DPCR AND QPCR MARKET: ECOSYSTEM ANALYSIS
5.9.1 DPCR AND QPCR MARKET: ROLE OF RAW MATERIAL SUPPLIERS
TABLE 12 DPCR AND QPCR MARKET: RAW MATERIAL SUPPLIERS
5.9.2 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS
TABLE 13 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS
5.9.3 DPCR AND QPCR MARKET: ROLE OF END USERS
TABLE 14 DPCR AND QPCR MARKET: ROLE OF END USERS
5.9.4 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES
TABLE 15 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES
5.10 PATENT ANALYSIS
5.10.1 PATENT METHODOLOGY
5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
TABLE 16 PATENTS FILED, 2014–2024
5.10.3 INNOVATION & PATENT APPLICATIONS
FIGURE 28 NUMBER OF PATENTS GRANTED, 2014–2024
5.10.4 TOP APPLICANTS
FIGURE 29 TOP TEN PATENT APPLICANTS, 2014–2024
TABLE 17 TOP 20 PATENT OWNERS IN QPCR AND DPCR MARKET, 2014–2024
5.11 KEY CONFERENCES AND EVENTS (2024?2025)
TABLE 18 DPCR AND QPCR MARKET: LIST OF CONFERENCES AND EVENTS (2024?2025)
5.12 REGULATORY LANDSCAPE
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12.2 REGULATORY SCENARIO
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DPCR & QPCR PRODUCTS
5.13.2 KEY BUYING CRITERIA AMONG END USERS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
TABLE 20 BUYING CRITERIA FOR DPCR AND QPCR PRODUCTS, BY END USER
5.14 INVESTMENT & FUNDING SCENARIO
5.15 TRADE ANALYSIS
TABLE 21 IMPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSANDS)
TABLE 22 EXPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 23 IMPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)
TABLE 24 EXPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)
6 DPCR AND QPCR MARKET, BY OFFERING
6.1 INTRODUCTION
TABLE 25 DPCR AND QPCR MARKET, BY OFFERING, 2022–2029 (USD MILLION)
6.2 QPCR OFFERINGS
TABLE 26 QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 27 QPCR OFFERING MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 MIDDLE EAST: QPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 33 GCC COUNTRIES: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.1 QPCR PRODUCTS
TABLE 34 QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.2.1.1 qPCR reagents & consumables
6.2.1.1.1 Recurring consumption of detection agents to drive market
TABLE 35 QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 36 NORTH AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 EUROPE: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 ASIA PACIFIC: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 LATIN AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 MIDDLE EAST: QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 41 GCC COUNTRIES: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 QPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 43 QPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022–2029 (USD MILLION)
6.2.1.2 qPCR instruments
6.2.1.2.1 Advancements in instrument design to drive market
TABLE 44 INSTALLED BASE FOR QPCR INSTRUMENTS, BY PRODUCT, 2019?2023
TABLE 45 QPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 NORTH AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 EUROPE: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 ASIA PACIFIC: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 LATIN AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 MIDDLE EAST: QPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 GCC COUNTRIES: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 53 QPCR INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
6.2.2 QPCR SOFTWARE
6.2.2.1 Rising demand for specialized analysis software to support market growth
TABLE 54 QPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 55 NORTH AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 EUROPE: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 ASIA PACIFIC: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 LATIN AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 MIDDLE EAST: QPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 60 GCC COUNTRIES: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 QPCR SOFTWARE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 62 QPCR SOFTWARE MARKET, BY END USER, 2022–2029 (USD MILLION)
6.2.3 QPCR SERVICES
6.2.3.1 Growing requirement for maintenance and calibration of PCR instruments to fuel market
TABLE 63 QPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 64 NORTH AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 EUROPE: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 ASIA PACIFIC: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 LATIN AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 MIDDLE EAST: QPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 69 GCC COUNTRIES: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 QPCR SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 71 QPCR SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
6.3 DPCR OFFERINGS
TABLE 72 DPCR OFFERINGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 73 DPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 NORTH AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 EUROPE: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 ASIA PACIFIC: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 LATIN AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 MIDDLE EAST: DPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 79 GCC COUNTRIES: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1 DPCR PRODUCTS
TABLE 80 DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.3.1.1 DPCR reagents & consumables
6.3.1.1.1 Availability of novel dPCR reagents to propel market
TABLE 81 DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 MIDDLE EAST: DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 87 GCC COUNTRIES: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 DPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 89 DPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022–2029 (USD MILLION)
6.3.1.2 DPCR instruments
TABLE 90 DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 DPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 EUROPE: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 99 DPCR INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
6.3.1.2.1 Droplet digital PCR
6.3.1.2.1.1 High accuracy and time efficiency benefits to fuel uptake
TABLE 100 DROPLET DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 EUROPE: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 ASIA PACIFIC: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 LATIN AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 MIDDLE EAST: DROPLET DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 106 GCC COUNTRIES: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2.2 Chip-based digital PCR
6.3.1.2.2.1 High-throughput capabilities to boost demand
TABLE 107 CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 108 NORTH AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 EUROPE: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 ASIA PACIFIC: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 LATIN AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 MIDDLE EAST: CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 113 GCC COUNTRIES: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2.3 Beaming digital PCR
6.3.1.2.3.1 Growing applications in oncology diagnostics to support market growth
TABLE 114 BEAMING DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 115 NORTH AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 EUROPE: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 LATIN AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 MIDDLE EAST: BEAMING DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 GCC COUNTRIES: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.2 DPCR SOFTWARE
6.3.2.1 Ability to enhance workflow efficiency to drive market
TABLE 121 DPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 122 NORTH AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 EUROPE: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 ASIA PACIFIC: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 LATIN AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 MIDDLE EAST: DPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 127 GCC COUNTRIES: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 DPCR SOFTWARE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 129 DPCR SOFTWARE MARKET, BY END USER, 2022–2029 (USD MILLION)
6.3.3 DPCR SERVICES
6.3.3.1 Rising need for application-specific guidance to support market growth
TABLE 130 DPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 131 NORTH AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 EUROPE: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 LATIN AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 MIDDLE EAST: DPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 136 GCC COUNTRIES: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 DPCR SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 138 DPCR SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
7 DPCR AND QPCR MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 139 QPCR AND DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
7.2 QPCR APPLICATIONS
TABLE 140 APPLICATION EXAMPLES OF QPCR
TABLE 141 QPCR APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
7.2.1 CLINICAL APPLICATIONS
TABLE 142 QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 143 QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.1 Infectious disease testing
7.2.1.1.1 Wide utilization in pathogen testing to fuel market
TABLE 150 QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 151 NORTH AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 EUROPE: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 ASIA PACIFIC: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 LATIN AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 MIDDLE EAST: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 156 GCC COUNTRIES: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.2 Oncology testing
7.2.1.2.1 High uptake in tumor screening & classification to boost demand
TABLE 157 QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 158 NORTH AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 EUROPE: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 ASIA PACIFIC: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 LATIN AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 MIDDLE EAST: QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 163 GCC COUNTRIES: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.3 Blood screening
7.2.1.3.1 Elimination of post-amplification processing to drive market
TABLE 164 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 165 NORTH AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 EUROPE: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 ASIA PACIFIC: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 LATIN AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 MIDDLE EAST: QPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 170 GCC COUNTRIES: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.4 Transplant diagnostics
7.2.1.4.1 Growing preference for genome-based products to fuel market
TABLE 171 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 ASIA PACIFIC: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 LATIN AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 MIDDLE EAST: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 177 GCC COUNTRIES: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.5 Other clinical applications
TABLE 178 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 179 NORTH AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 EUROPE: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 ASIA PACIFIC: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 MIDDLE EAST: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 184 GCC COUNTRIES: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2 RESEARCH APPLICATIONS
TABLE 185 QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 186 QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 187 NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 192 GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2.1 Single-cell analysis
7.2.2.1.1 Growing need for high-resolution molecular data to drive market
TABLE 193 QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 194 NORTH AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 EUROPE: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022–2029 (USD MILLION)
TABLE 196 ASIA PACIFIC: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022–2029 (USD MILLION)
TABLE 197 LATIN AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 MIDDLE EAST: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 199 GCC COUNTRIES: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2.2 Stem cell research
7.2.2.2.1 Growing focus on regenerative medicine to boost demand
TABLE 200 QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 201 NORTH AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 EUROPE: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 ASIA PACIFIC: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 LATIN AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 MIDDLE EAST: QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 206 GCC COUNTRIES: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2.3 Gene expression
7.2.2.3.1 Precise quantification requirements to support market growth
TABLE 207 QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 EUROPE: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 ASIA PACIFIC: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 LATIN AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 MIDDLE EAST: QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION)
TABLE 213 GCC COUNTRIES: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2.4 Other research applications
TABLE 214 QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 215 NORTH AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 EUROPE: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 ASIA PACIFIC: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 LATIN AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 MIDDLE EAST: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 220 GCC COUNTRIES: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.3 FORENSIC APPLICATIONS
7.2.3.1 Ability to analyze genetic fingerprinting and biological samples to propel market
TABLE 221 QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 222 NORTH AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 EUROPE: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 ASIA PACIFIC: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 LATIN AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 MIDDLE EAST: QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 227 GCC COUNTRIES: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.4 ENVIRONMENTAL APPLICATIONS
7.2.4.1 Development of specialized assays for environmental monitoring to drive market
TABLE 228 QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 229 NORTH AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 EUROPE: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 LATIN AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 MIDDLE EAST: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 234 GCC COUNTRIES: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.5 OTHER QPCR APPLICATIONS
TABLE 235 OTHER QPCR APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 236 NORTH AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 ASIA PACIFIC: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 LATIN AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 MIDDLE EAST: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 241 GCC COUNTRIES: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 DPCR APPLICATIONS
TABLE 242 DPCR APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
7.3.1 CLINICAL APPLICATIONS
TABLE 243 DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 245 NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 248 LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 250 GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.1.1 Infectious disease testing
7.3.1.1.1 Accuracy and precision capabilities to boost demand
TABLE 251 DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 252 NORTH AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 EUROPE: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 ASIA PACIFIC: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 255 LATIN AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 MIDDLE EAST: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 257 GCC COUNTRIES: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.1.2 Oncology testing
7.3.1.2.1 Detection and monitoring of cancer-related genetic alterations to drive market
TABLE 258 DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 259 NORTH AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260 EUROPE: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 ASIA PACIFIC: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 262 LATIN AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 MIDDLE EAST: DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 264 GCC COUNTRIES: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.1.3 Blood screening
7.3.1.3.1 Highly sensitive detection of infectious agents to support market growth
TABLE 265 DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 266 NORTH AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 267 EUROPE: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 ASIA PACIFIC: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 269 LATIN AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 MIDDLE EAST: DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 271 GCC COUNTRIES: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKETS COVERED
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONS COVERED
FIGURE 1 REGIONAL SEGMENTATION
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
FIGURE 3 DPCR AND QPCR MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 DIGITAL PCR (DPCR) AND QUANTITATIVE PCR (QPCR) MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
2.2.1 GLOBAL MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 6 ILLUSTRATIVE EXAMPLE OF QIAGEN N.V.: REVENUE SHARE ANALYSIS (2023)
2.2.2 INSIGHTS OF PRIMARY EXPERTS
FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.2.3 SEGMENTAL MARKET SIZE ESTIMATION
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE PROJECTIONS
FIGURE 9 DPCR AND QPCR MARKET: CAGR PROJECTIONS, 2024–2029
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT ANALYSIS
2.7 RESEARCH LIMITATIONS
2.8 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 11 QPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 12 DPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 13 QPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 DPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 QPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 DPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET
4 PREMIUM INSIGHTS
4.1 DIGITAL PCR (DPCR) AND QUANTITATIVE/REAL-TIME PCR (QPCR) MARKET OVERVIEW
FIGURE 18 RISING INCIDENCE OF INFECTIOUS DISEASES AND GENETIC DISORDERS TO DRIVE MARKET DURING FORECAST PERIOD
4.2 ASIA PACIFIC: QPCR MARKET, BY OFFERING AND COUNTRY (2024)
FIGURE 19 QPCR PRODUCTS SEGMENT IN CHINA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
4.3 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET
FIGURE 20 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 DPCR AND QPCR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 3 DPCR AND QPCR MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of infectious diseases and genetic disorders
TABLE 4 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION (2022)
5.2.1.2 Increasing advancements in PCR technologies
TABLE 5 CONVENTIONAL PCR VS. QPCR & DPCR
5.2.1.3 Increasing applications of PCR in biomarker discovery
5.2.1.4 Growing focus on dPCR and qPCR technologies for POC diagnostics
5.2.2 RESTRAINTS
5.2.2.1 High cost of dPCR instruments
5.2.2.2 Technical limitations associated with qPCR and dPCR
5.2.2.3 Unfavorable reimbursements for diagnostic companies
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of emerging markets
5.2.3.2 Integration of qPCR and dPCR with NGS
5.2.3.3 Growing significance of RT-PCR-based companion diagnostics in drug development
5.2.4 CHALLENGES
5.2.4.1 Time constraints associated with sample handling
5.2.4.2 Inadequate protocols for accuracy & standardization
5.2.4.3 Availability of alternative technologies
5.3 PORTER’S FIVE FORCES ANALYSIS
FIGURE 22 DPCR AND QPCR MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6 DPCR AND QPCR MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 DEGREE OF COMPETITION
5.3.2 BARGAINING POWER OF SUPPLIERS
5.3.3 BARGAINING POWER OF BUYERS
5.3.4 THREAT OF SUBSTITUTES
5.3.5 THREAT OF NEW ENTRANTS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 23 DPCR AND QPCR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 TECHNOLOGY ANALYSIS
5.5.1 KEY TECHNOLOGIES
TABLE 7 KEY TECHNOLOGIES
5.5.2 COMPLEMENTARY TECHNOLOGIES
TABLE 8 COMPLEMENTARY TECHNOLOGIES
5.5.3 ADJACENT TECHNOLOGIES
TABLE 9 ADJACENT TECHNOLOGIES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 24 SUPPLY CHAIN ANALYSIS
5.7 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING RAW MATERIAL PROCUREMENT AND MANUFACTURING STAGES
5.8 PRICING ANALYSIS
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT (2023)
FIGURE 26 AVERAGE SELLING PRICE TREND FOR QPCR INSTRUMENTS (2021?2023)
TABLE 11 AVERAGE SELLING PRICE, BY PRODUCT, BY REGION (2023)
5.9 ECOSYSTEM ANALYSIS
FIGURE 27 DPCR AND QPCR MARKET: ECOSYSTEM ANALYSIS
5.9.1 DPCR AND QPCR MARKET: ROLE OF RAW MATERIAL SUPPLIERS
TABLE 12 DPCR AND QPCR MARKET: RAW MATERIAL SUPPLIERS
5.9.2 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS
TABLE 13 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS
5.9.3 DPCR AND QPCR MARKET: ROLE OF END USERS
TABLE 14 DPCR AND QPCR MARKET: ROLE OF END USERS
5.9.4 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES
TABLE 15 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES
5.10 PATENT ANALYSIS
5.10.1 PATENT METHODOLOGY
5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
TABLE 16 PATENTS FILED, 2014–2024
5.10.3 INNOVATION & PATENT APPLICATIONS
FIGURE 28 NUMBER OF PATENTS GRANTED, 2014–2024
5.10.4 TOP APPLICANTS
FIGURE 29 TOP TEN PATENT APPLICANTS, 2014–2024
TABLE 17 TOP 20 PATENT OWNERS IN QPCR AND DPCR MARKET, 2014–2024
5.11 KEY CONFERENCES AND EVENTS (2024?2025)
TABLE 18 DPCR AND QPCR MARKET: LIST OF CONFERENCES AND EVENTS (2024?2025)
5.12 REGULATORY LANDSCAPE
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12.2 REGULATORY SCENARIO
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DPCR & QPCR PRODUCTS
5.13.2 KEY BUYING CRITERIA AMONG END USERS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
TABLE 20 BUYING CRITERIA FOR DPCR AND QPCR PRODUCTS, BY END USER
5.14 INVESTMENT & FUNDING SCENARIO
5.15 TRADE ANALYSIS
TABLE 21 IMPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSANDS)
TABLE 22 EXPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 23 IMPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)
TABLE 24 EXPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)
6 DPCR AND QPCR MARKET, BY OFFERING
6.1 INTRODUCTION
TABLE 25 DPCR AND QPCR MARKET, BY OFFERING, 2022–2029 (USD MILLION)
6.2 QPCR OFFERINGS
TABLE 26 QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 27 QPCR OFFERING MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 MIDDLE EAST: QPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 33 GCC COUNTRIES: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.1 QPCR PRODUCTS
TABLE 34 QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.2.1.1 qPCR reagents & consumables
6.2.1.1.1 Recurring consumption of detection agents to drive market
TABLE 35 QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 36 NORTH AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 EUROPE: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 ASIA PACIFIC: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 LATIN AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 MIDDLE EAST: QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 41 GCC COUNTRIES: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 QPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 43 QPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022–2029 (USD MILLION)
6.2.1.2 qPCR instruments
6.2.1.2.1 Advancements in instrument design to drive market
TABLE 44 INSTALLED BASE FOR QPCR INSTRUMENTS, BY PRODUCT, 2019?2023
TABLE 45 QPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 NORTH AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 EUROPE: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 ASIA PACIFIC: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 LATIN AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 MIDDLE EAST: QPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 GCC COUNTRIES: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 53 QPCR INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
6.2.2 QPCR SOFTWARE
6.2.2.1 Rising demand for specialized analysis software to support market growth
TABLE 54 QPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 55 NORTH AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 EUROPE: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 ASIA PACIFIC: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 LATIN AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 MIDDLE EAST: QPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 60 GCC COUNTRIES: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 QPCR SOFTWARE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 62 QPCR SOFTWARE MARKET, BY END USER, 2022–2029 (USD MILLION)
6.2.3 QPCR SERVICES
6.2.3.1 Growing requirement for maintenance and calibration of PCR instruments to fuel market
TABLE 63 QPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 64 NORTH AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 EUROPE: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 ASIA PACIFIC: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 LATIN AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 MIDDLE EAST: QPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 69 GCC COUNTRIES: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 QPCR SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 71 QPCR SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
6.3 DPCR OFFERINGS
TABLE 72 DPCR OFFERINGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 73 DPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 NORTH AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 EUROPE: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 ASIA PACIFIC: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 LATIN AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 MIDDLE EAST: DPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 79 GCC COUNTRIES: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1 DPCR PRODUCTS
TABLE 80 DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.3.1.1 DPCR reagents & consumables
6.3.1.1.1 Availability of novel dPCR reagents to propel market
TABLE 81 DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 MIDDLE EAST: DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 87 GCC COUNTRIES: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 DPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 89 DPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022–2029 (USD MILLION)
6.3.1.2 DPCR instruments
TABLE 90 DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 DPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 EUROPE: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 99 DPCR INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
6.3.1.2.1 Droplet digital PCR
6.3.1.2.1.1 High accuracy and time efficiency benefits to fuel uptake
TABLE 100 DROPLET DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 EUROPE: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 ASIA PACIFIC: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 LATIN AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 MIDDLE EAST: DROPLET DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 106 GCC COUNTRIES: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2.2 Chip-based digital PCR
6.3.1.2.2.1 High-throughput capabilities to boost demand
TABLE 107 CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 108 NORTH AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 EUROPE: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 ASIA PACIFIC: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 LATIN AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 MIDDLE EAST: CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 113 GCC COUNTRIES: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1.2.3 Beaming digital PCR
6.3.1.2.3.1 Growing applications in oncology diagnostics to support market growth
TABLE 114 BEAMING DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 115 NORTH AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 EUROPE: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 LATIN AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 MIDDLE EAST: BEAMING DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 GCC COUNTRIES: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.2 DPCR SOFTWARE
6.3.2.1 Ability to enhance workflow efficiency to drive market
TABLE 121 DPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 122 NORTH AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 EUROPE: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 ASIA PACIFIC: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 LATIN AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 MIDDLE EAST: DPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 127 GCC COUNTRIES: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 DPCR SOFTWARE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 129 DPCR SOFTWARE MARKET, BY END USER, 2022–2029 (USD MILLION)
6.3.3 DPCR SERVICES
6.3.3.1 Rising need for application-specific guidance to support market growth
TABLE 130 DPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 131 NORTH AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 EUROPE: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 LATIN AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 MIDDLE EAST: DPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 136 GCC COUNTRIES: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 DPCR SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 138 DPCR SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
7 DPCR AND QPCR MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 139 QPCR AND DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
7.2 QPCR APPLICATIONS
TABLE 140 APPLICATION EXAMPLES OF QPCR
TABLE 141 QPCR APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
7.2.1 CLINICAL APPLICATIONS
TABLE 142 QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 143 QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.1 Infectious disease testing
7.2.1.1.1 Wide utilization in pathogen testing to fuel market
TABLE 150 QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 151 NORTH AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 EUROPE: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 ASIA PACIFIC: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 LATIN AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 MIDDLE EAST: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 156 GCC COUNTRIES: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.2 Oncology testing
7.2.1.2.1 High uptake in tumor screening & classification to boost demand
TABLE 157 QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 158 NORTH AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 EUROPE: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 ASIA PACIFIC: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 LATIN AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 MIDDLE EAST: QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 163 GCC COUNTRIES: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.3 Blood screening
7.2.1.3.1 Elimination of post-amplification processing to drive market
TABLE 164 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 165 NORTH AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 EUROPE: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 ASIA PACIFIC: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 LATIN AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 MIDDLE EAST: QPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 170 GCC COUNTRIES: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.4 Transplant diagnostics
7.2.1.4.1 Growing preference for genome-based products to fuel market
TABLE 171 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 ASIA PACIFIC: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 LATIN AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 MIDDLE EAST: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 177 GCC COUNTRIES: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.1.5 Other clinical applications
TABLE 178 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 179 NORTH AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 EUROPE: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 ASIA PACIFIC: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 MIDDLE EAST: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 184 GCC COUNTRIES: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2 RESEARCH APPLICATIONS
TABLE 185 QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 186 QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 187 NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 192 GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2.1 Single-cell analysis
7.2.2.1.1 Growing need for high-resolution molecular data to drive market
TABLE 193 QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 194 NORTH AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 EUROPE: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022–2029 (USD MILLION)
TABLE 196 ASIA PACIFIC: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022–2029 (USD MILLION)
TABLE 197 LATIN AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 MIDDLE EAST: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 199 GCC COUNTRIES: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2.2 Stem cell research
7.2.2.2.1 Growing focus on regenerative medicine to boost demand
TABLE 200 QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 201 NORTH AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 EUROPE: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 ASIA PACIFIC: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 LATIN AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 MIDDLE EAST: QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 206 GCC COUNTRIES: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2.3 Gene expression
7.2.2.3.1 Precise quantification requirements to support market growth
TABLE 207 QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 EUROPE: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 ASIA PACIFIC: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 LATIN AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 MIDDLE EAST: QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION)
TABLE 213 GCC COUNTRIES: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.2.4 Other research applications
TABLE 214 QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 215 NORTH AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 EUROPE: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 ASIA PACIFIC: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 LATIN AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 MIDDLE EAST: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 220 GCC COUNTRIES: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.3 FORENSIC APPLICATIONS
7.2.3.1 Ability to analyze genetic fingerprinting and biological samples to propel market
TABLE 221 QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 222 NORTH AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 EUROPE: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 ASIA PACIFIC: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 LATIN AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 MIDDLE EAST: QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 227 GCC COUNTRIES: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.4 ENVIRONMENTAL APPLICATIONS
7.2.4.1 Development of specialized assays for environmental monitoring to drive market
TABLE 228 QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 229 NORTH AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 EUROPE: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 LATIN AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 MIDDLE EAST: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 234 GCC COUNTRIES: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.2.5 OTHER QPCR APPLICATIONS
TABLE 235 OTHER QPCR APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 236 NORTH AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 ASIA PACIFIC: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 LATIN AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 MIDDLE EAST: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 241 GCC COUNTRIES: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 DPCR APPLICATIONS
TABLE 242 DPCR APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
7.3.1 CLINICAL APPLICATIONS
TABLE 243 DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 245 NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 248 LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 250 GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.1.1 Infectious disease testing
7.3.1.1.1 Accuracy and precision capabilities to boost demand
TABLE 251 DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 252 NORTH AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 EUROPE: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 ASIA PACIFIC: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 255 LATIN AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 MIDDLE EAST: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 257 GCC COUNTRIES: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.1.2 Oncology testing
7.3.1.2.1 Detection and monitoring of cancer-related genetic alterations to drive market
TABLE 258 DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 259 NORTH AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260 EUROPE: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 ASIA PACIFIC: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 262 LATIN AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 MIDDLE EAST: DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 264 GCC COUNTRIES: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
7.3.1.3 Blood screening
7.3.1.3.1 Highly sensitive detection of infectious agents to support market growth
TABLE 265 DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 266 NORTH AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 267 EUROPE: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 ASIA PACIFIC: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 269 LATIN AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 MIDDLE EAST: DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 271 GCC COUNTRIES: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
